Chronic obstructive pulmonary disease : a systemic inflammatory disease /

Saved in:
Bibliographic Details
Other Authors: Nakamura, Hiroyuki (Editor), Aoshiba, Kazutetsu (Editor)
Format: Book
Language:English
Published: Singapore : Springer, [2017]
Series:Respiratory disease series,
Subjects:
Online Access:Elektronická verze přístupná pouze pro studenty a pracovníky MU
Related Items:Tištěná verze:: Chronic obstructive pulmonary disease : a systemic inflammatory disease.
LEADER 05342cam a22005897i 4500
001 MUB03000005210
003 CZ BrMU
005 20230405072244.0
008 180803t20172017io |||||o|||||||||||eng d
STA |a EIZ  |b 333  |c EBSCO trvale nakupy  |d 2018-07-31 
020 |a 978-981-10-0839-9  |q (eBook) 
035 |a (OCoLC)ocn962154564 
035 |a (OCoLC)962154564  |z (OCoLC)961910167  |z (OCoLC)962017240 
040 |a EBLCP  |b cze  |e rda  |c EBLCP  |d N$T  |d YDX  |d GW5XE  |d N$T  |d OCLCQ  |d IDEBK  |d OCLCF  |d UAB  |d IOG  |d ESU  |d JBG  |d IAD  |d ICW  |d ICN  |d OTZ  |d OCLCQ  |d U3W  |d CAUOI  |d OCLCQ  |d BOD034 
072 7 |a 616  |x Patologie. Klinická medicína  |2 Konspekt  |9 14 
080 |a 616.24-007/-008  |2 MRF 
080 |a 616.24  |2 MRF 
245 0 0 |a Chronic obstructive pulmonary disease :  |b a systemic inflammatory disease /  |c Hiroyuki Nakamura, Kazutetsu Aoshiba, editors 
264 1 |a Singapore :  |b Springer,  |c [2017] 
264 4 |c ©2017 
300 |a 1 online zdroj (xi, 351 stran) :  |b ilustrace 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
490 1 |a Respiratory Disease Series,  |x 2509-5552 
505 0 |a Preface; References; Contents; Part I: Definition and Epidemiology; Chapter 1: Definition of Chronic Obstructive Pulmonary Disease (COPD): Is the Latest GOLD Classification of Severity Still Val ... ; 1.1 Introduction; 1.2 Historical Transition of the Concept of COPD; 1.3 Difference Between COPD and Bronchial Asthma; 1.4 Chronic Bronchitis and Pulmonary Emphysema; 1.5 Global Initiative for Chronic Obstructive Lung Disease (GOLD); 1.6 Combined COPD Assessment; 1.7 Conclusion; References; Chapter 2: Epidemiology of COPD: Why Is the Disease So Poorly Recognized?; 2.1 Introduction. 
505 8 |a 2.2 Risk Factors of COPD2.2.1 Cigarette Smoking; 2.2.2 Other Risk Factors; 2.2.2.1 Genetic Factors; 2.2.2.2 Environmental Factors; Occupational Airborne Particles; Air Pollution; Indoor Air Pollutants; Outdoor Air Pollution; 2.2.2.3 Low Socioeconomic Status; 2.3 Decline in FEV1 in Patients with COPD; 2.4 Incidence of COPD; 2.5 Prevalence of COPD; 2.6 Undiagnosed COPD; 2.7 Impact of COPD on Health Status in the General Population; 2.8 Conclusions; References; Part II: Genetic Predisposition and Pathogenic Mechanisms. 
505 8 |a Chapter 3: Genetic Predisposition to COPD: Are There Any Relevant Genes Determining the Susceptibility to Smoking?3.1 Introduction; 3.2 Investigation of the Genes Related to COPD Pathogenesis: The Era Before GWAS; 3.3 Genome-Wide Association Studies (GWASs) for Susceptibility Genes of COPD; 3.4 Recent Progress of Studies of COPD Genetics in GWAS Era (I): Relevant Genes Determining the Susceptibility to Smoking; 3.5 Recent Progress of Studies of COPD Genetics in GWAS Era (II): Gene Related to Critical Subtypes or Phenotypes of COPD. 
505 8 |a 3.6 Recent Progress of Studies of COPD Genetics in GWAS Era (III): Novel Strategy for Research on COPD Genetics with Multi-omi ... 3.7 Recent Progress of Studies of COPD Genetics in GWAS Era (IV): Next-Generation Sequencing and Arrays; 3.8 Recent Progress of Studies of COPD Genetics in GWAS Era (V): Pharmacogenetics and Pharmacogenomics in COPD; 3.9 Conclusions; References; Chapter 4: Pathogenesis of COPD (Persistence of Airway Inflammation): Why Does Airway Inflammation Persist After Cessation of ... ; 4.1 Introduction; 4.2 Airway Inflammation and Changes in COPD. 
505 8 |a 4.2.1 Airway Structure and Mucus Production in Patients with COPD4.2.2 Lung Destruction in COPD; 4.2.3 Inflammatory Cells and Cytokines in the Airway in COPD; 4.3 Airway Inflammation After Smoking Cessation; 4.3.1 Innate Immune System; 4.3.1.1 The Role of TLRs; 4.3.1.2 The Role of NLRs; 4.3.1.3 The Role of RLRs; 4.3.1.4 The Role of RAGE; 4.3.2 Adaptive Immune System; 4.3.2.1 The Role of B Cells; 4.3.2.2 The Role of T Cells; 4.3.3 COPD Deterioration After Smoking Cessation; 4.3.3.1 COPD Deterioration by COPD Itself; 4.3.3.2 COPD Deterioration by Latent Respiratory Infection. 
533 |a Elektronická reprodukce.  |n Přístup pouze pro oprávněné uživatele 
650 0 7 |a plicní nemoci  |2 czmesh 
650 0 7 |a chronická obstrukční plicní nemoc  |2 czmesh 
650 0 2 |a Lung Diseases 
650 0 2 |a Pulmonary Disease, Chronic Obstructive 
655 7 |a e-knihy online  |2 CZ-BrMU 
655 9 |a e-books online  |2 eCZ-BrMU 
700 1 |a Nakamura, Hiroyuki  |4 edt 
700 1 |a Aoshiba, Kazutetsu  |4 edt 
776 0 8 |i Tištěná verze:  |t Chronic obstructive pulmonary disease : a systemic inflammatory disease.  |z 978-981-10-0838-2 
830 0 |a Respiratory disease series,  |x 2509-5552 
856 4 1 |z Elektronická verze přístupná pouze pro studenty a pracovníky MU  |u https://ezproxy.muni.cz/login?url=https://search.ebscohost.com/login.aspx?authtype=ip&custid=s8431878&lang=cs&profile=eds&direct=true&db=nlebk&AN=1282162 
CAT |c 20180803  |l MUB03  |h 1520 
CAT |c 20190222  |l MUB03  |h 1623 
CAT |c 20190222  |l MUB03  |h 1659 
CAT |c 20210421  |l MUB03  |h 2124 
CAT |c 20210421  |l MUB03  |h 2208 
CAT |a VARTECKA  |b 02  |c 20230405  |l MUB03  |h 0722 
995 |a eBook 
994 - 1 |l MUB03  |l MUB03  |m EBOOK  |1 KUK  |a Knihovna univ. kampusu  |2 VV  |b KUK - volný výběr  |5 3284L00488  |8 20180801  |f 83  |f Dálkově přístupná  |s kup 
AVA |a MED50  |b KUK  |c KUK - volný výběr  |e available  |t K dispozici  |f 1  |g 0  |h N  |i 0  |j VV